{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:48Z","timestamp":1753891068653,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hemolytic\u2013uremic syndrome (HUS) can occur as a systemic complication of infection with Shiga toxin (Stx)-producing Escherichia coli (STEC). Most well-known aspects of the pathophysiology are secondary to microthrombotic kidney disease including hemolytic anemia and thrombocytopenia. However, extrarenal manifestations, such as cardiac impairment, have also been reported. We have investigated whether these cardiac abnormalities can be reproduced in a murine animal model, in which administration of Stx, the main virulence factor of STEC, is used to induce HUS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mice received either one high or multiple low doses of Stx to simulate the (clinically well-known) different disease courses. Cardiac function was evaluated by echocardiography and analyses of biomarkers in the plasma (troponin I and brain natriuretic peptide).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All Stx-challenged mice showed reduced cardiac output and depletion of intravascular volume indicated by a reduced end-diastolic volume and a higher hematocrit. Some mice exhibited myocardial injury (measured as increases in cTNI levels). A subset of mice challenged with either dosage regimen showed hyperkalemia with typical electrocardiographic abnormalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Myocardial injury, intravascular volume depletion, reduced cardiac output, and arrhythmias as a consequence of hyperkalemia may be prognosis-relevant disease manifestations of HUS, the significance of which should be further investigated in future preclinical and clinical studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1252818","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T07:44:22Z","timestamp":1695368662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic\u2013uremic syndrome: a pilot study"],"prefix":"10.3389","volume":"14","author":[{"given":"Charles","family":"Neu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianka","family":"Wissuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Thiemermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina M.","family":"Coldewey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of shiga toxin-producing escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: A prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins4111261","article-title":"Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals","volume":"4","author":"Mayer","year":"2012","journal-title":"Toxins (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with shiga toxin-producing escherichia coli (Stec hus)","volume":"34","author":"Khalid","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3736-y","article-title":"Hus-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue","volume":"32","author":"Andersen","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1343-6","article-title":"Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure","volume":"19","author":"Askiti","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-002-1039-3","article-title":"Cardiac ischemia during hemolytic uremic syndrome","volume":"18","author":"Thayu","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2019.28.2","article-title":"Troponins, acute coronary syndrome and renal disease: from acute kidney injury through end-stage kidney disease","volume":"14","author":"Banerjee","year":"2019","journal-title":"Eur Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951115002759","article-title":"Biomarkers detect involvement of acute myocardial injury in a paediatric haemolytic-uraemic syndrome patient","volume":"26","author":"Palanca Arias","year":"2016","journal-title":"Cardiol Young"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.65.1.115","article-title":"The importance of nonrenal involvement in hemolytic-uremic syndrome","volume":"65","author":"Upadhyaya","year":"1980","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/BF00858990","article-title":"Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome","volume":"9","author":"Gallo","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(88)80093-5","article-title":"The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing escherichia coli infections","volume":"19","author":"Richardson","year":"1988","journal-title":"Hum Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/327980","article-title":"Acute systolic heart failure associated with complement-mediated hemolytic uremic syndrome","volume":"2015","author":"Vaughn","year":"2015","journal-title":"Case Rep Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/2324709619842905","article-title":"Atypical hemolytic uremic syndrome presenting as acute heart failure-a rare presentation: diagnosis supported by skin biopsy","volume":"7","author":"Kichloo","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01459","article-title":"Modeling hemolytic-uremic syndrome: in-depth characterization of distinct murine models reflecting different features of human disease","volume":"9","author":"Dennhardt","year":"2018","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2918-0","article-title":"Hemoconcentration: A major risk factor for neurological involvement in hemolytic uremic syndrome","volume":"30","author":"Ardissino","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-015-1194-7","article-title":"Ultrasound findings in ehec-associated hemolytic-uremic syndrome and their clinical relevance","volume":"48","author":"Reising","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.5.H2520","article-title":"Measurement of cardiac output in small laboratory animals using recordings of blood conductivity","volume":"273","author":"Vogel","year":"1997","journal-title":"Am J Physiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.05.027","article-title":"Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock","volume":"1863","author":"Matsiukevich","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn649","article-title":"Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome","volume":"24","author":"Mohammed","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2022.05.011","article-title":"Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by shiga toxin-producing escherichia coli O26:H11 in France","volume":"29","author":"Minary","year":"2022","journal-title":"Arch Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/bf00858440","article-title":"A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the southwest pediatric nephrology study group","volume":"4","author":"Argyle","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"B24","article-title":"Haemolytic uraemic syndrome in childhood: an experience of 7 years at the Aga Khan University","volume":"48","author":"Ibrahim","year":"1998","journal-title":"J Pak Med Assoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-017-0021-x","article-title":"Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China","volume":"13","author":"Zhao","year":"2017","journal-title":"World J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/adc.72.1.46","article-title":"Myocarditis and haemolytic uraemic syndrome","volume":"72","author":"Abu-Arafeh","year":"1995","journal-title":"Arch Dis Child"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0785","article-title":"Predictors of fatality in postdiarrheal hemolytic uremic syndrome","volume":"117","author":"Oakes","year":"2006","journal-title":"Pediatrics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1252818\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T07:44:27Z","timestamp":1695368667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1252818\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":27,"alternative-id":["10.3389\/fimmu.2023.1252818"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1252818","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"article-number":"1252818"}}